4
Changes in Ownership
Definium Therapeutics, Inc. Filed Acc 0001209191-23-019896
Chief Executive Officer acquired 400,000 shares (grant or award)
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Barrow Robert Chief Executive Officer | 2023-03-14 | Grant or award | +400,000 | 638,959 | D |
Loading xslF345X03/doc4.xml…